Clinical Trials Directory

Trials / Completed

CompletedNCT05592444

Strategies to Reduce Contrast Medium in Spectral CT Pulmonary Angiography

Different Strategies to Reduce Contrast Medium in Computed Tomography Pulmonary Angiography Using Spectral Detector CT

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
330 (actual)
Sponsor
University Hospital, Akershus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the effect of three different strategies to inject at reduced volume of contrast medium in Computed Tomography Pulmonary Angiography (CTPA). 330 patients referred for CTPA are randomized to receive either a low-concentration, a low-volume or a saline-diluted injection. Effects on the level and homogeneity of contrast enhancement are measured and compared between groups.

Detailed description

Spectral detector CT facilitates large reductions in contrast medium in vascular CT examinations. To our knowledge, no studies have so far compared different strategies to inject this reduced contrast dose. The purpose of this study is to assess the effect of three different strategies to inject at reduced volume of contrast medium in Computed Tomography Pulmonary Angiography (CTPA). 330 patients referred for clinically indicated CTPA are randomized to receive either a low-concentration, a low-volume or a saline-diluted injection. All patients receive the same amount of iodine (140 mg/kg). Effects on the level and homogeneity of contrast enhancement, image noise, contrast-to-noise-ratio and signal-to-noise-ratio are measured in the CT images and the results are compared between groups.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLow iodine Spectral Detector CT Pulmonary AngiographyLow iodine Spectral Detector CT Pulmonary Angiography

Timeline

Start date
2020-11-23
Primary completion
2021-10-12
Completion
2021-10-12
First posted
2022-10-24
Last updated
2024-04-16

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05592444. Inclusion in this directory is not an endorsement.